A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyond.

ABSTRACT: Prior to the COVID-19 pandemic, the majority of clinical trial activity took place face to face within clinical or research units. The COVID-19 pandemic resulted in a significant shift towards trial delivery without in-person face-to-face contact or "Remote Trial Delivery". The National Institute of Health Research (NIHR) assembled a Remote Trial Delivery Working Group to consider challenges and enablers to this major change in clinical trial delivery and to provide a toolkit for researchers to support the transition to remote delivery. The NIHR Remote Trial Delivery Working Group evaluated five key domains of the trial delivery pathway: participant factors, recruitment, intervention delivery, outcome measurement and quality assurance. Independent surveys were disseminated to research prof

SUBMITTER: Masoli JAH 

PROVIDER: S-EPMC8665850 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature